Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis

NCT05001984 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Intracranial Atherosclerosis
Acute Ischemic Stroke
ICAS - Intracranial Atherosclerosis

Interventions

DRUG: Alirocumab

Sponsor

Chang Gung Memorial Hospital

Collaborators

[object Object]